Skip to content
The Nexus
DossierENTITY

pharmaceutical pricing policies

Coverage of pharmaceutical pricing policies in the Nexus archive.

Earliest in view: Jun 19 · 03:10 UTCMost recent: Jun 19 · 03:10 UTC
Co-mentioned in this coverage
United Statesplace1Germanyplace1Section 301 trade authoritiestopic1tariffstopic1
Recent coverage
  • BUSINESSJun 19 · 03:10 UTCFRANCE 24
    US launches Germany pharma pricing probe, raising threat of new tariffs

    The United States has launched an investigation into Germany's pharmaceutical pricing policies, which could lead to new tariffs. The probe, under Section 301 trade authorities, examines whether Germany's practices underpay for innovative medicines and harm US commerce.